A standardized procedure for using human corpus cavernosum strips to evaluate drug activity

Citation
V. Mirone et al., A standardized procedure for using human corpus cavernosum strips to evaluate drug activity, J PHARM TOX, 44(3), 2000, pp. 477-482
Citations number
10
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
ISSN journal
10568719 → ACNP
Volume
44
Issue
3
Year of publication
2000
Pages
477 - 482
Database
ISI
SICI code
1056-8719(200011/12)44:3<477:ASPFUH>2.0.ZU;2-7
Abstract
The main problem of using human corpus cavernosum (HCC) tissue to perform b ioassay is linked to its limited availability further complicated by the he terogeneous source of the tissues used. Here, we show that gender reassignm ent is a reliable source of human tissue without major ethical problems. In deed, the entire corpus cavernosum is obtained from the surgery procedure, which allows creating a standardized procedure to prepare HCC strip. In add ition, human tissue, if kept in the fridge in the condition described, does not loose its ability to contract to phenylephrine (PE; alpha agonist), an giotensin IT (AG II) and KCl up to 4 days. Furthermore, once contracted wit h PE, HCC relaxes to acetylcholine (endothelium-dependent mechanism); sodiu m nitroprusside (endothelium-independent mechanism); cromakalim (CRK), a K- ATP channel opener; or alprostadil, a synthetic PGE(2) (ALPR). In conclusio n, we have standardized a procedure that allows the use of HCC strips to ev aluate drug activity and/or to study pathophysiological mechanisms with an intact functional human tissue up to 4 days from the surgery procedure. (C) 2001 Elsevier Science Inc. All rights reserved.